| Literature DB >> 23874138 |
Kemebradikumo Pondei1, Beleudanyo G Fente, Oluwatoyosi Oladapo.
Abstract
BACKGROUND: Wound infections continue to be problematic in clinical practice where empiric treatment of infections is routine.Entities:
Keywords: antimicrobial resistance; bacteria; wound infection
Year: 2013 PMID: 23874138 PMCID: PMC3705182 DOI: 10.2149/tmh.2012-14
Source DB: PubMed Journal: Trop Med Health ISSN: 1348-8945
Age distribution of patients with significant bacterial growth
| Age group | Total no. of swabs | No. of infected swabs | p value | |
|---|---|---|---|---|
| Male | Female | |||
| 0 to 10 | 12 | 7 | 4 | 0.23 |
| 11 to 20 | 12 | 4 | 7 | |
| 21 to 30 | 33 | 11 | 14 | |
| 31 to 40 | 9 | 4 | 4 | |
| 41 to 50 | 8 | 3 | 3 | |
| 51 to 60 | 12 | 6 | 5 | |
| 61 to 70 | 7 | 2 | 5 | |
| 70 | 8 | 2 | 6 | |
| Total | 101 | 39 | 48 | |
Frequency of wound types
| Type of wound | no. of swabs | no. of infected swabs | Patients with infected wounds | |
|---|---|---|---|---|
| Males | Females | |||
| Surgical | 31(30.69%) | 27 (87%) | 6 | 21 |
| Trauma | 22 (21.78%) | 22 (100%) | 21 | 1 |
| Non-traumatic | 40 (39.6%) | 32 (80%) | 10 | 22 |
| Burns | 8 (7.92%) | 6 (75%) | 2 | 4 |
| Total | 101 | 87 | 39 | 48 |
Frequency of micro-organism isolated
| Micro-organism isolated | Male | Female | p value |
|---|---|---|---|
| 11 | 28 | ||
| 7 | 6 | 0.6601 | |
| Coliform (except | 8 | 4 | |
| 6 | 4 | ||
| 5 | 2 | ||
| 2 | 4 | ||
| Total | 39 | 48 |
Frequency of micro-organisms according to wound types
| Micro-organism | Type of wound | Total | |||
|---|---|---|---|---|---|
| Surgical | Trauma | Non-traumatic | Burns | ||
| 7 | 9 | 19 | 4 | 39 | |
| 2 | 9 | 2 | 0 | 13 | |
| Coliform (except | 6 | 0 | 4 | 2 | 12 |
| 3 | 2 | 5 | 0 | 10 | |
| 5 | 2 | 0 | 0 | 7 | |
| 4 | 0 | 2 | 0 | 6 | |
| Total | 27 | 22 | 32 | 6 | 87 |
Degree of susceptibility of micro-organisms isolated to antibiotics expressed in percentage resistance
| Organism | CAZ | CTX | NIT | CXC | AMX-CLA | GEN | CRX | OFL |
|---|---|---|---|---|---|---|---|---|
| 66.7 | 82 | 94.9 | 100 | 94.9 | 58.9 | 92.3 | 58.9 | |
| 84.6 | 100 | 100 | 100 | 76.9 | 46.1 | 46.1 | 61.5 | |
| Coliform (except | 63.6 | 63.6 | 63.6 | 100 | 100 | 81.8 | 63.6 | 81.8 |
| 50 | 50 | 70 | 100 | 80 | 90 | 80 | 80 | |
| 42.8 | 85.7 | 28.6 | 100 | 100 | 57.1 | 57.1 | 100 | |
| 33.3 | 50 | 50 | 100 | 100 | 50 | 83.3 | 83.3 |
CAZ—ceftazidime; CTX—cefotaxime; NIT—nitrofurantoin; CXC—cloxacillin; AMX-CLA—amoxicillin-clavulanic acid; GEN—gentamicin; CRX—cefuroxime; OFL—oflaxacin
Fig. 1.Susceptibility pattern of Pseudomonas aeruginosa isolates to antimicrobial agents.
CAZ—ceftazidime; CTX—cefotaxime; NIT—nitrofurantoin; CXC—cloxacillin; AMX-CLA—amoxicillin-clavulanic acid; GEN—gentamicin; CRX—cefuroxime; OFL—oflaxacin